OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Lenvatinib in Patients With Advanced Grade 1/2 Pancreatic and Gastrointestinal Neuroendocrine Tumors: Results of the Phase II TALENT Trial (GETNE1509)
Jaume Capdevila, Nicola Fazio, Carlos López, et al.
Journal of Clinical Oncology (2021) Vol. 39, Iss. 20, pp. 2304-2312
Open Access | Times Cited: 80
Jaume Capdevila, Nicola Fazio, Carlos López, et al.
Journal of Clinical Oncology (2021) Vol. 39, Iss. 20, pp. 2304-2312
Open Access | Times Cited: 80
Showing 1-25 of 80 citing articles:
European Neuroendocrine Tumor Society (ENETS ) 2023 guidance paper for colorectal neuroendocrine tumours
Anja Rinke, Valentina Ambrosini, Clarisse Dromain, et al.
Journal of Neuroendocrinology (2023) Vol. 35, Iss. 6
Open Access | Times Cited: 66
Anja Rinke, Valentina Ambrosini, Clarisse Dromain, et al.
Journal of Neuroendocrinology (2023) Vol. 35, Iss. 6
Open Access | Times Cited: 66
Phase 3 Trial of Cabozantinib to Treat Advanced Neuroendocrine Tumors
Jennifer A. Chan, Susan M. Geyer, Tyler Zemla, et al.
New England Journal of Medicine (2024)
Closed Access | Times Cited: 19
Jennifer A. Chan, Susan M. Geyer, Tyler Zemla, et al.
New England Journal of Medicine (2024)
Closed Access | Times Cited: 19
Durvalumab plus tremelimumab for the treatment of advanced neuroendocrine neoplasms of gastroenteropancreatic and lung origin
Jaume Capdevila, Jorge Hernando, Àlex Teulé, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 31
Jaume Capdevila, Jorge Hernando, Àlex Teulé, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 31
European Neuroendocrine Tumor Society (ENETS) 2024 guidance paper for the management of well‐differentiated small intestine neuroendocrine tumours
Ángela Lamarca, Detlef K. Bartsch, Martyn Caplin, et al.
Journal of Neuroendocrinology (2024) Vol. 36, Iss. 9
Open Access | Times Cited: 15
Ángela Lamarca, Detlef K. Bartsch, Martyn Caplin, et al.
Journal of Neuroendocrinology (2024) Vol. 36, Iss. 9
Open Access | Times Cited: 15
Vascular Endothelial Growth Factor Receptors in the Vascularization of Pancreatic Tumors: Implications for Prognosis and Therapy
C.J. Grobbelaar, Vanessa Steenkamp, Peace Mabeta
Current Issues in Molecular Biology (2025) Vol. 47, Iss. 3, pp. 179-179
Open Access | Times Cited: 1
C.J. Grobbelaar, Vanessa Steenkamp, Peace Mabeta
Current Issues in Molecular Biology (2025) Vol. 47, Iss. 3, pp. 179-179
Open Access | Times Cited: 1
Pancreatic Neuroendocrine Tumors: Molecular Mechanisms and Therapeutic Targets
Chandra K. Maharjan, Po Hien Ear, Catherine G. Tran, et al.
Cancers (2021) Vol. 13, Iss. 20, pp. 5117-5117
Open Access | Times Cited: 52
Chandra K. Maharjan, Po Hien Ear, Catherine G. Tran, et al.
Cancers (2021) Vol. 13, Iss. 20, pp. 5117-5117
Open Access | Times Cited: 52
Phase II study of pembrolizumab and lenvatinib in advanced well-differentiated neuroendocrine tumors
Taymeyah Al‐Toubah, Michael J. Schell, Brian Morse, et al.
ESMO Open (2024) Vol. 9, Iss. 4, pp. 102386-102386
Open Access | Times Cited: 7
Taymeyah Al‐Toubah, Michael J. Schell, Brian Morse, et al.
ESMO Open (2024) Vol. 9, Iss. 4, pp. 102386-102386
Open Access | Times Cited: 7
Targeting Tyrosine kinases in Renal Cell Carcinoma: “New Bullets against Old Guys”
Teresa Alonso‐Gordoa, Laura García‐Bermejo, Enrique Grande, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 8, pp. 1901-1901
Open Access | Times Cited: 49
Teresa Alonso‐Gordoa, Laura García‐Bermejo, Enrique Grande, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 8, pp. 1901-1901
Open Access | Times Cited: 49
Management of Appendix Neuroendocrine Neoplasms: Insights on the Current Guidelines
Amr Mohamed, Sulin Wu, Mohamed E. Hamid, et al.
Cancers (2022) Vol. 15, Iss. 1, pp. 295-295
Open Access | Times Cited: 27
Amr Mohamed, Sulin Wu, Mohamed E. Hamid, et al.
Cancers (2022) Vol. 15, Iss. 1, pp. 295-295
Open Access | Times Cited: 27
Update in the management of gastroenteropancreatic neuroendocrine tumors
Andrew J. H. Sedlack, Diana Grace Varghese, Amirkia Naimian, et al.
Cancer (2024) Vol. 130, Iss. 18, pp. 3090-3105
Closed Access | Times Cited: 5
Andrew J. H. Sedlack, Diana Grace Varghese, Amirkia Naimian, et al.
Cancer (2024) Vol. 130, Iss. 18, pp. 3090-3105
Closed Access | Times Cited: 5
Neuroendocrine Tumors: a Relevant Clinical Update
Emma N. Rizen, Alexandria T. Phan
Current Oncology Reports (2022) Vol. 24, Iss. 6, pp. 703-714
Closed Access | Times Cited: 22
Emma N. Rizen, Alexandria T. Phan
Current Oncology Reports (2022) Vol. 24, Iss. 6, pp. 703-714
Closed Access | Times Cited: 22
A phase II study of ramucirumab and somatostatin analog therapy in patients with advanced neuroendocrine tumors
Kimberly Perez, Matthew H. Kulke, Hui Zheng, et al.
The Oncologist (2025) Vol. 30, Iss. 1
Open Access
Kimberly Perez, Matthew H. Kulke, Hui Zheng, et al.
The Oncologist (2025) Vol. 30, Iss. 1
Open Access
A Review of FDA-Approved Multi-Target Angiogenesis Drugs for Brain Tumor Therapy
Iuliana Mihaela Buzatu, Ligia Gabriela Tătăranu, Carmen Duță, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 5, pp. 2192-2192
Open Access
Iuliana Mihaela Buzatu, Ligia Gabriela Tătăranu, Carmen Duță, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 5, pp. 2192-2192
Open Access
Eastern Canadian Gastrointestinal Cancer Consensus Conference 2024
Jennifer Leigh, Atique U. Ahmed, F. Aubin, et al.
Current Oncology (2025) Vol. 32, Iss. 3, pp. 175-175
Open Access
Jennifer Leigh, Atique U. Ahmed, F. Aubin, et al.
Current Oncology (2025) Vol. 32, Iss. 3, pp. 175-175
Open Access
Combining anti-PD-1 antibodies with surufatinib for gastrointestinal neuroendocrine carcinoma: Two cases report and review of literature
Likun Gao, Dong-Ni Gao, Harvey Yuan, et al.
World Journal of Clinical Oncology (2025) Vol. 16, Iss. 4
Closed Access
Likun Gao, Dong-Ni Gao, Harvey Yuan, et al.
World Journal of Clinical Oncology (2025) Vol. 16, Iss. 4
Closed Access
Surufatinib in advanced neuroendocrine tumours: Final overall survival from two randomised, double-blind, placebo-controlled phase 3 studies (SANET-ep and SANET-p)
Jianming Xu, Lin Shen, Jie Li, et al.
European Journal of Cancer (2025), pp. 115398-115398
Closed Access
Jianming Xu, Lin Shen, Jie Li, et al.
European Journal of Cancer (2025), pp. 115398-115398
Closed Access
Regorafenib plus avelumab in advanced gastroenteropancreatic neuroendocrine neoplasms: a phase 2 trial and correlative analysis
Sophie Cousin, Jean‐Philippe Guégan, Lola‐Jade Palmieri, et al.
Nature Cancer (2025)
Closed Access
Sophie Cousin, Jean‐Philippe Guégan, Lola‐Jade Palmieri, et al.
Nature Cancer (2025)
Closed Access
Tumores Neuroendocrinos Gastroenteropancreáticos
Andrés Rodríguez, Greta Catani, Oscar Andriani, et al.
Oncología Clínica (2025) Vol. 30, Iss. 1
Closed Access
Andrés Rodríguez, Greta Catani, Oscar Andriani, et al.
Oncología Clínica (2025) Vol. 30, Iss. 1
Closed Access
Emerging Treatment Options for Gastroenteropancreatic Neuroendocrine Tumors
Mauro Cives, Eleonora Pellè, Jonathan Strosberg
Journal of Clinical Medicine (2020) Vol. 9, Iss. 11, pp. 3655-3655
Open Access | Times Cited: 30
Mauro Cives, Eleonora Pellè, Jonathan Strosberg
Journal of Clinical Medicine (2020) Vol. 9, Iss. 11, pp. 3655-3655
Open Access | Times Cited: 30
The Mount Sinai Clinical Pathway for the Diagnosis and Management of Hypercortisolism due to Ectopic ACTH Syndrome
Eva L. Alba, Emily Japp, Gustavo Fernandez‐Ranvier, et al.
Journal of the Endocrine Society (2022) Vol. 6, Iss. 7
Open Access | Times Cited: 17
Eva L. Alba, Emily Japp, Gustavo Fernandez‐Ranvier, et al.
Journal of the Endocrine Society (2022) Vol. 6, Iss. 7
Open Access | Times Cited: 17
The Landmark Series: Surgical Management of Functioning and Non-Functioning Pancreatic Neuroendocrine Tumors
Joseph Tobias, Callisia N. Clarke, Alexandra Gangi, et al.
Annals of Surgical Oncology (2025)
Open Access
Joseph Tobias, Callisia N. Clarke, Alexandra Gangi, et al.
Annals of Surgical Oncology (2025)
Open Access
Pancreatic neuroendocrine neoplasms: Updates on genomic changes in inherited tumour syndromes and sporadic tumours based on WHO classification
Hirotaka Ishida, Alfred K. Lam
Critical Reviews in Oncology/Hematology (2022) Vol. 172, pp. 103648-103648
Open Access | Times Cited: 16
Hirotaka Ishida, Alfred K. Lam
Critical Reviews in Oncology/Hematology (2022) Vol. 172, pp. 103648-103648
Open Access | Times Cited: 16
Therapy Sequencing in Patients With Advanced Neuroendocrine Neoplasms
Rachel P. Riechelmann, Rodrigo G. Taboada, Victor Hugo Fonseca de Jesus, et al.
American Society of Clinical Oncology Educational Book (2023), Iss. 43
Open Access | Times Cited: 9
Rachel P. Riechelmann, Rodrigo G. Taboada, Victor Hugo Fonseca de Jesus, et al.
American Society of Clinical Oncology Educational Book (2023), Iss. 43
Open Access | Times Cited: 9
SEOM-GETNE clinical guidelines for the diagnosis and treatment of gastroenteropancreatic and bronchial neuroendocrine neoplasms (NENs) (2022)
Jaume Capdevila, Teresa Alonso Gordoa, Alberto Carmona‐Bayonas, et al.
Clinical & Translational Oncology (2023) Vol. 25, Iss. 9, pp. 2692-2706
Open Access | Times Cited: 8
Jaume Capdevila, Teresa Alonso Gordoa, Alberto Carmona‐Bayonas, et al.
Clinical & Translational Oncology (2023) Vol. 25, Iss. 9, pp. 2692-2706
Open Access | Times Cited: 8
The role of serotonin inhibition within the treatment of carcinoid syndrome
Joel George, John Ramage, Benjamin White, et al.
Endocrine Oncology (2023) Vol. 3, Iss. 1
Open Access | Times Cited: 7
Joel George, John Ramage, Benjamin White, et al.
Endocrine Oncology (2023) Vol. 3, Iss. 1
Open Access | Times Cited: 7
